Sleep Apnoea Treatment Gets New Drug Approval
Big news! The US Food and Drug Administration has given the go-ahead for Eli Lilly's new drug, Zepbound, to treat adults with both sleep apnoea and obesity. This could be a game-changer for the company, as it looks to expand its successful weight-loss drug business. The drug was shown to significantly improve symptoms in nearly half of the clinical trial patients wit...